ScholarX

Browsing by Cho, Byoung ChulAuthor

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
전체 가 나 다 라 마 바 사 아 자 차 카 타 파 하

Showing results 1 to 20 of 38

SCOPUS
A brief report on stable disease among amivantamab-treated patients with post-platinum epidermal growth factor receptor exon 20 insertion–mutated non-small cell lung cancer: A response-based analysis from the CHRYSALIS studyopen access

Girard, Nicolas; Park, Keunchil; Lee, Se-Hoon; Viteri, Santiago; Schioppa, Claudio A.; Diels, Joris; Oguz, Mustafa; Rodrigues, Bernardo H.; Rahhali, Nora; Sermon, Jan, et al.

ArticleIssue Date2024CitationCancer Treatment and Research Communications, v.40PublisherElsevier Ltd
SCIESCOPUS
A first-in-human, phase 1/2a study of GI-102 (CD80-IL2v3) in patients with advanced or metastatic solid tumors: Initial results from dose escalation

Lee, Jeeyun; Cho, Byoung Chul; Lee, Jae-Lyun; Lee, Jung-Yun; Ma, Wen Wee; Adjei, Alex A.; Campian, Jian Li; Zhao, Yujie; Seetharam, Mahesh; Shim, Byoung Yong, et al.

ArticleIssue Date2024CitationJOURNAL OF CLINICAL ONCOLOGY, v.42, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
A phase 1b study of cofetuzumab pelidotin monotherapy in patients with PTK7-expressing recurrent non-small cell lung canceropen access

Cho, Byoung Chul; Johnson, Melissa; Bar, Jair; Schaefer, Eric; Yoh, Kiyotaka; Zer, Alona; Moskovitz, Mor; Lee, Se-Hoon; Moreno, Victor; de Miguel, Maria, et al.

ArticleIssue Date2025CitationLung Cancer, v.202PublisherElsevier Ireland Ltd
SCIESCOPUS
A phase 2 study of spartalizumab (PDR001) among patients with recurrent or metastatic esophageal squamous cell carcinoma (KCSG HN18-17, K-MASTER project 12)open access

Lee, Dong Ki; Park, Sook Ryun; Kim, Yeul Hong; Lee, Yun-Gyoo; Shin, Su-Jin; Ahn, Beung-Chul; Lee, Sung Sook; Lim, Sun Min; Kim, Hye Ryun; Cho, Byoung Chul, et al.

ArticleIssue Date2024CitationONCOIMMUNOLOGY, v.13, no.1PublisherTAYLOR & FRANCIS INC
SCIESCOPUS
Amivantamab in EGFR Exon 20 Insertion-Mutated Non-Small-Cell Lung Cancer Progressing on Platinum Chemotherapy: Initial Results From the CHRYSALIS Phase I Studyopen access

Park, Keunchil; Haura, Eric B.; Leighl, Natasha B.; Mitchell, Paul; Shu, Catherine A.; Girard, Nicolas; Viteri, Santiago; Han, Ji-Youn; Kim, Sang-We; Lee, Chee Khoon, et al.

ArticleIssue Date2021CitationJOURNAL OF CLINICAL ONCOLOGY, v.39, no.30, pp 3391 - 3402PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 Insertions

Zhou, Caicun; Tang, Ke-Jing; Cho, Byoung Chul; Liu, Baogang; Paz-Ares, Luis; Cheng, Susanna; Kitazono, Satoru; Thiagarajan, Muthukkumaran; Goldman, Jonathan W.; Sabari, Joshua K., et al.

ArticleIssue Date2023CitationNEW ENGLAND JOURNAL OF MEDICINE, v.389, no.22, pp 2039 - 2051PublisherMASSACHUSETTS MEDICAL SOC
SCIESCOPUS
Amivantamab plus lazertinib in atypical <i>EGFR</i>-mutated advanced non-small cell lung cancer (NSCLC): Results from CHRYSALIS-2

Cho, Byoung Chul; Wang, Yongsheng; Felip, Enriqueta; Cui, Jiuwei; Spira, Alexander I.; Neal, Joel W.; Baik, Christina; Marmarelis, Melina Elpi; Ichihara, Eiki; Lee, Jong-Seok, et al.

ArticleIssue Date2024CitationJOURNAL OF CLINICAL ONCOLOGY, v.42, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Amivantamab Plus Lazertinib in Patients With EGFR-Mutant NSCLC After Progression on Osimertinib and Platinum-Based Chemotherapy: Results From CHRYSALIS-2 Cohort A

Besse, Benjamin; Goto, Koichi; Wang, Yongsheng; Lee, Se-Hoon; Marmarelis, Melina E.; Ohe, Yuichiro; Bernabe Caro, Reyes; Kim, Dong-Wan; Lee, Jong-Seok; Cousin, Sophie, et al.

ArticleIssue Date2025CitationJournal of Thoracic OncologyPublisherElsevier Inc.
SCIESCOPUS
Amivantamab Plus Lazertinib vs Osimertinib as First-line Treatment in Patients With EGFR-mutated, Advanced Nonsmall Cell Lung Cancer (NSCLC): Primary Results From MARIPOSA, a Phase 3, Global, Randomized, Controlled Trial (Previously presented at ESMO Congress 2023, FPN:LBA14, Byoung Chul Cho et al. - Reused with permission.)

Schuler, Martin; Cho, Byoung Chul; Felip, Enriqueta; Spira, Alexander; Girard, Niolas; Lee, Jong-Seok; Lee, Se-Hoon; Ostapenko, Yuriy; Danchaivijitr, Pongwut; Liu, Baogang, et al.

ArticleIssue Date2024CitationONCOLOGY RESEARCH AND TREATMENT, v.47, pp 260 - 261PublisherKARGER
SCIESCOPUS
Amivantamab plus lazertinib vs osimertinib in first-line EGFR<i>-</i>mutant advanced non-small cell lung cancer (NSCLC) with biomarkers of high-risk disease: A secondary analysis from the phase 3 MARIPOSA study

Felip, Enriqueta; Cho, Byoung Chul; Gutierrez, Vanesa; Alip, Adlinda; Besse, Benjamin; Lu, Shun; Spira, Alexander I.; Girard, Nicolas; Califano, Raffaele; Gadgeel, Shirish M., et al.

ArticleIssue Date2024CitationJOURNAL OF CLINICAL ONCOLOGY, v.42, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Anti-cytotoxic T-lymphocyte-associated antigen-4 monoclonal antibody quavonlimab in combination with pembrolizumab: Safety and efficacy from a phase I study in previously treated extensive-stage small cell lung cancer

Cho, Byoung Chul; Yoh, Kiyotaka; Perets, Ruth; Nagrial, Adnan; Spigel, David R.; Gutierrez, Martin; Kim, Dong-Wan; Kotasek, Dusan; Rasco, Drew; Niu, Jiaxin, et al.

ArticleIssue Date2021CitationLUNG CANCER, v.159, pp 162 - 170PublisherELSEVIER IRELAND LTD
SCIESCOPUS
Anti-TIGIT Antibody Tiragolumab Alone or With Atezolizumab in Patients With Advanced Solid Tumors A Phase 1a/1b Nonrandomized Controlled Trialopen access

Kim, Tae Won; Bedard, Philippe L.; Lorusso, Patricia; Gordon, Michael S.; Bendell, Johanna; Oh, Do-Youn; Ahn, Myung-Ju; Garralda, Elena; D'Angelo, Sandra P.; Desai, Jayesh, et al.

ArticleIssue Date2023CitationJAMA ONCOLOGY, v.9, no.11, pp 1574 - 1582PublisherAMER MEDICAL ASSOC
SCIESCOPUS
Bintrafusp Alfa Versus Pembrolizumab in Patients With Treatment-Naive, Programmed Death-Ligand 1–High Advanced NSCLC: A Randomized, Open-Label, Phase 3 Trial

Cho, Byoung Chul; Lee, Jong Seok; Wu, Yi-Long; Cicin, Irfan; Dols, Manuel Cobo; Ahn, Myung-Ju; Cuppens, Kristof; Veillon, Rémi; Nadal, Ernest; Dias, Josiane Mourão, et al.

ArticleIssue Date2023CitationJournal of Thoracic Oncology, v.18, no.12, pp 1731 - 1742PublisherElsevier Inc.
SCIESCOPUS
Central Nervous System Outcomes of Lazertinib Versus Gefitinib in EGFR-Mutated Advanced NSCLC: A LASER301 Subset Analysisopen access

Soo, Ross A.; Cho, Byoung Chul; Kim, Joo-Hang; Ahn, Myung-Ju; Lee, Ki Hyeong; Zimina, Anastasia; Orlov, Sergey; Bondarenko, Igor; Lee, Yun-Gyoo; Lim, Yueh Ni, et al.

ArticleIssue Date2023CitationJournal of Thoracic Oncology, v.18, no.12, pp 1756 - 1766PublisherElsevier Inc.
SCISCIESCOPUS
Characteristics and Outcome of ROS1-Positive Non-Small Cell Lung Cancer Patients in Routine Clinical Practiceopen access

Park, Sehhoon; Ahn, Beung-Chul; Lim, Sung Won; Sun, Jong-Mu; Kim, Hye Ryun; Hong, Min Hee; Lee, Se-Hoon; Ahn, Jin Seok; Park, Keunchil; La Choi, Yoon, et al.

ArticleIssue Date2018CitationJOURNAL OF THORACIC ONCOLOGY, v.13, no.9, pp 1373 - 1382PublisherELSEVIER SCIENCE INC
SCIESCOPUS
Datopotamab Deruxtecan in Advanced or Metastatic Non–Small Cell Lung Cancer With Actionable Genomic Alterations Results From the Phase II TROPION-Lung05 Study

Sands, Jacob; Ahn, Myung-Ju; Lisberg, Aaron; Cho, Byoung Chul; Blumenschein, George; Shum, Elaine; Tostivint, Elvire Pons; Goto, Yasushi; Yoh, Kiyotaka; Heist, Rebecca, et al.

ArticleIssue Date2025CitationJournal of Clinical Oncology, v.43, no.10PublisherLippincott Williams and Wilkins
SCIESCOPUS
Durvalumab in Combination With Olaparib Versus Durvalumab Alone as Maintenance Therapy in Metastatic NSCLC: The Phase 2 ORION Studyopen access

Ahn, Myung-Ju; Bondarenko, Igor; Kalinka, Ewa; Cho, Byoung Chul; Sugawara, Shunichi; Gálffy, Gabriella; Shim, Byoung Yong; Kislov, Nikolay; Nagarkar, Rajnish; Demedts, Ingel, et al.

ArticleIssue Date2023CitationJournal of Thoracic Oncology, v.18, no.11, pp 1594 - 1606PublisherElsevier Inc.
SCIESCOPUS
Durvalumab With or Without Tremelimumab vs Standard Chemotherapy in First-line Treatment of Metastatic Non-Small Cell Lung Cancer The MYSTIC Phase 3 Randomized Clinical Trialopen access

Rizvi, Naiyer A.; Cho, Byoung Chul; Reinmuth, Niels; Lee, Ki Hyeong; Luft, Alexander; Ahn, Myung-Ju; van den Heuvel, Michel M.; Cobo, Manuel; Vicente, David; Smolin, Alexey, et al.

ArticleIssue Date2020CitationJAMA ONCOLOGY, v.6, no.5, pp 661 - 674PublisherAMER MEDICAL ASSOC
SCIESCOPUS
Early Clearance of Plasma Epidermal Growth Factor Receptor Mutations as a Predictor of Outcome on Osimertinib in Advanced Non-Small Cell Lung Cancer; Exploratory Analysis from AURA3 and FLAURA

Gray, Jhanelle E.; Ahn, Myung-Ju; Oxnard, Geoffrey R.; Shepherd, Frances A.; Imamura, Fumio; Cheng, Ying; Okamoto, Isamu; Cho, Byoung Chul; Lin, Meng-Chih; Wu, Yi-Long, et al.

ArticleIssue Date2023CitationCLINICAL CANCER RESEARCH, v.29, no.17, pp 3340 - 3351PublisherAMER ASSOC CANCER RESEARCH
SCIESCOPUS
First-line pembrolizumab (pembro) plus chemotherapy (chemo) for advanced esophageal cancer: 5-year outcomes from the phase 3 KEYNOTE-590 study.

Shah, Manish A.; Sun, Jong-Mu; Shen, Lin; Kato, Ken; Enzinger, Peter C.; Adenis, Antoine; Doi, Toshihiko; Kojima, Takashi; Li, Zhigang; Kim, Sung-Bae, et al.

ArticleIssue Date2024CitationJOURNAL OF CLINICAL ONCOLOGY, v.42, no.3_SUPPL, pp 250 - 250PublisherLIPPINCOTT WILLIAMS & WILKINS
1 2
STATISTICS
Total View:
Daily View:

RSS_1.0 RSS_2.0 ATOM_1.0

CONTACT US

(03063) 25-2, SUNGKYUNKWAN-RO, JONGNO-GU, SEOUL, KOREA samsunglib@skku.edu

COPYRIGHT © 2021 SUNGKYUNKWAN UNIVERSITY ALL RIGHTS RESERVED.

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

BROWSE

한국어